All I see here is more dilution as far as the eye can see. They do not make money and seeing that they have gone to a HODL strategy only, dilution is the only way they can fund operations. Thiel makes it way too easy for the shorts. Probably the best company to short on the market.

And if that scenario did play out, I would be the first to join a class action lawsuit against them.

If I have learned anything from this company it is to expect absolutely nothing, because that is exactly what they have given us for many years now. This POS is toast, of that I have no doubt.

And if Reinhardt did buy the company back do you seriously think he will keep it public...or maybe take it private?

I have been holding shares for over 2 years and always think that one day they will let it run...my mistake. These MFers will never let it run. This is the most blatantly manipulated stock I have ever owned.

I think you are right. They will probably drag it down under $10 by Friday. These algos and shorts have complete control now and are frigging ruthless. If Thiel is continuing to dilute then this is hopeless for a long time.

Between the shorts and/or dilution, they frigging crushing this POS!

Just thinking out loud here. "If" it is the ETF's and certain funds that are continually shorting the piss out of MARA, and/or other miners, why? Could it be that they want to ultimately buy these miners for dirt cheap to guarantee a steady stream of Bitcoin going forward? Or, could they want to damage the stock and reduce the options the miners have to raise capital, thus forcing the miners to sell more of their Bitcoin to sustain operations?

It looks like the shorts have a different idea and they are tenacious. Of course the company could be doing this via dilution. Either way...it sucks!

IMO, not until the company announced they are done diluting the piss out of us. This stock is heavily shorted and diluted. I think eventually they will see stock appreciation but until the company gives us more clarity on the dilution, I wouldn't touch it. That being said, I have accumulated 6,000 shares over the last 2 years with an average cost of $10 and have not sold a share.

Jesus frigging Christ, how many shares do these aholes have to short, or is this mostly naked shorts. The shorting and dilution here is relentless.

Sure wish I had sold 40% last week. This has been way too easy for the shorts. When they do another round of dilution, I will be joining the shorts.

Yes, .10 a share. I am hedging my bet in case they actually bring this thing back to life. If you are making a serious offer, you must have reason to believe it will come back. They have never responded to my emails so I am completely blind but you may not be.

I can't respond privately so will do it here. Absolutely, I would be interested in selling my shares to you. I am going to give them time to respond to the SEC complaint before selling. If it looks like Reinhard will let it die on the vine, as someone else suggested, then you can have all of my 800,000 shares for .10 a share. Subject to change, of course.

Of course, if I could!

That has been my hope for years but at this point, I seriously doubt there is any value here. If I remember correctly, this thing was fast tracked for phase 3 testing almost 20 years ago and Reinhard has been unable to even start it. If there was any value here, someone would have found it by now.

And so far, very wrong. Their opinion is usually couched in vague optimism but it is obvious to me, this turkey is done. They were fast tracked for phase 3 many years ago and have done squat, not to mention they have been dark for 2 or 3 years. I am pretty sure this will go down as a losing pick for Altitrade.
However, they will be the first to say "win some, lose some".

That may be true but as long as they co tinue to increase the authorized shares and requests for increased compensation based on stock, the shorts will be licking their chops. This has proven to be a dilution machine and the shorts know there will always be shares available to cover...if need be.

Sarepta also works in the gene therapy world and is having major issues. I am curious if they would be interested in buying this...if there is really anything to buy?

There appears to be an endless supply of shares available to sell/short or just flat out naked shorting. I am not experienced enough to figure it out but something is very wrong here. The downward pressure is relentless.

Looks like they will sell/short it back down to $4.00. Thank you, Mr. Thiel. As long as he continues to dilute, this will continue.

Unfortunate that offer was fake, but had suspected as much. Face it folks, if these yahoos couldn't find financing during a pandemic, for a phase 3 fast track designated drug which "may" have been helpful for people suffering from COVID, they will never find it. Game over. Now just sell the shell and ride off into the sunset.

Got it. Yes, it might be viable as a shell but am pretty sure the current company will never succeed, let alone trade again.

I seriously doubt that. I believe they received the phase 3 fast track designation in 2007 and have not done squat. These guys are toast, IMHO.

Business Summary

Gene Biotherapeutics Inc. is a clinical-stage biotechnology company, which is focused on pre-clinical, clinical and commercialization of angiogenic gene therapy biotherapeutics for strategic niche markets primarily for the treatment of cardiovascular disease. The technology platform is designed to biologically activate the human body's innate angiogenic healing process to stimulate the growth of microvascular networks for patients with ischemic cardiovascular, cerebral, and other medical conditions and diseases, as well as for advanced tissue engineering applications. Its lead product candidate Generx (Ad5FGF-4) is an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. The Generx product candidate is under clinical development, which is cleared by the United States Food and Drug Administration (FDA) for a Phase III clinical study.

Come on CRXM...let's go!

I just looked back at this valuation comparison that management gave you and took a glance at TNYA's market cap. Was very surprised to see it was at $372m.

I know this management is prone to exaggeration or possibly even misguiding shareholders but even if they were off by a factor of 10, that would leave us with a $37M market cap and close to 45 cents per share. I would be ecstatic with that, hell, I would be ecstatic with half that.

Very interesting. Even if they did naked short us, it is still incumbent upon the company to keep all filings up to date, which they did not.

Bentleyt, while I want to share your optimism, I would caution you about getting too far over your skis here. If I remember correctly, you were told a few things before the company went into the abyss almost two years ago. I am still hopeful here but refuse to believe anything until I see it in official form. Fool me once....

docj, not a bad idea. I sold most of my shares before this pig went into the abyss but am still holding 800,000 shares. In my opinion, Reinhardt and company are just trying to slither away. If you follow the links you provided last week, it states the company has not even bugun to recruit patients for the Phase 3 trial yet. Toast!

I am guessing they never responded? Toast.

While that is somewhat comforting, if Nostrum will guarantee the principal, why don't they just provide the financing and get on with it? I still think this thing is toast.

Thanks for the response docj. Not exactly the ray of hope I was looking for, but thanks. In the current market environment, I seriously doubt they will have any takers and am more convinced these guys are toast. When a pinkie goes dark without a peep for a year, the writing is on the wall.

Docj, do you care to elaborate on why there may be reason to be optimistic in the next week or so? I would like to join your enthusiasm but honestly, I see no reason to believe these guys will continue as a viable entity, for current shareholders anyway.

Serious question, fatty. How does 189 shares even trade on this. Is it just some kind of book clean up or can someone actually buy at these prices? I am "extremely" cautiously optimistic here due to recent posts.

Thank you.

Thank you bentleyt. I appreciate that.

Thanks BS1. It sure would be nice if this turned around. I might even think my late wife had something to do with it. The truth is, if she knew I invested in this, I probably would have preceded her in death.

Thanks jtomm. Been a very rough couple of months.

Thanks fatty. I appreciate that.

"on a post IPO basis". Where does that leave current shareholders? This is encouraging, as long as existing shareholders are kept whole.

Thanks docj. Is this new info? It appears they are looking for $6m via an S1 filing to complete phase 3. If this is new info, it is promising. As an aside, my wife passed away a month ago from a second heart attack and I have to wonder if this therapy could have helped her.